This case involved five pharmacists employed by Drug Fair, a large retail drug store chain, who sued for unpaid overtime compensation under the Fair Labor Standards Act for hours worked over 40 per week during specified periods from 1963 to 1969. The court first addressed constitutional challenges, upholding the Act's application to retail enterprises engaged in commerce under the enterprise doctrine and confirming the validity of Wage and Hour Administrator regulations defining professional exemptions, including salary basis requirements. It determined that the plaintiffs were covered by the Act and entitled to overtime pay, as the employer's compensation practices did not qualify for exemption, but denied liquidated damages based on the employer's good faith belief in the exemption and lack of willful violation. The matter was referred to an auditor to calculate amounts due to each plaintiff, with attorneys' fees and costs to be addressed later.
labor & employmentbusiness & regulatoryfederal power
The case concerns a challenge by the Investment Company Institute and its members against the Comptroller of the Currency's 1963 regulation permitting national banks to commingle and collectively invest funds held as managing agents, as well as the Comptroller's approval of First National City Bank's specific Commingled Investment Account plan. Plaintiffs sought an injunction and declaratory judgment that the regulation and approvals violated 12 U.S.C. § 92a and the Glass-Steagall Act's prohibitions on banks engaging in securities activities. On cross-motions for summary judgment, the court reviewed the regulatory history, the registration of the Account with the SEC as an open-end investment company, and the operational similarities to mutual funds. The core reasoning centers on interpreting the scope of banks' fiduciary powers and whether the commingled accounts constitute prohibited underwriting or dealing in securities.
The case involves Maryland Casualty Company's request for a preliminary injunction to prevent American General Insurance from proceeding with a stock exchange offer to acquire Maryland's stock. The court denied the injunction, allowing the exchange to proceed under court-ordered restrictions that preserve Maryland's management, policies, personnel, and assets, and prevent certain actions like merging assets or changing operations until a final hearing. The reasoning included the plaintiff's failure to demonstrate a likelihood of success on the merits or irreparable harm, the willingness of Maryland's officers in prior negotiations, potential harm to defendants and stockholders from an injunction, and the need to avoid what would effectively be a final ruling without trial.
The case involved Graber Manufacturing Company and related parties seeking declaratory and injunctive relief against Federal Trade Commission commissioners to prevent public disclosure of confidential business documents during an antitrust proceeding under the Clayton Act as amended by the Robinson-Patman Act. The court held that the Commission's denial of permanent in camera status for a document estimating the plaintiffs' sales to a major customer constituted an abuse of discretion. The core reasoning was that the plaintiffs had shown good cause for confidentiality by demonstrating a clearly defined and serious risk of injury to their business from disclosure to competitors, which outweighed the general policy favoring public access to the record, while requiring compliance with a subpoena duces tecum subject to protections for business secrets.
This case was a civil action under 35 U.S.C. § 146 in which Polaroid Corporation and inventor Shurcliff sought a judgment that Shurcliff was the first inventor of a radiation detection unit or dosimeter, entitling Polaroid to the patent, after losing an interference proceeding to Horner and Gray. The court entered judgment for the defendants Horner and Gray. The core reasoning was that Shurcliff's work occurred under a Navy contract to develop a dosimeter based on a general plan originated by Horner and Gray's team, making his contributions ancillary improvements that inured to the benefit of the original conception holders under precedent such as Agawam Woolen Co. v. Jordan, and that Polaroid had not carried its burden to show the Board of Patent Interferences' priority ruling was erroneous.
This case is a patent interference action under 35 U.S.C. § 146 in which Minnesota Mining & Manufacturing Co., as assignee of Sommer and Pietrusza, sought to establish that its inventors had priority over Krieble (assignor to General Electric Co.) for a process of preparing monomeric organosilicon compounds, and that Krieble's patent was invalid or derived from the plaintiffs' work. The court dismissed the complaint after a de novo review. It held that the plaintiffs failed to provide independent corroboration of actual reduction to practice or diligence during the critical period, and that evidence of the defendants' knowledge of the Sommer-Pietrusza manuscript or contacts via DiGiorgio was insufficient to prove lack of originality or derivation.